Longeveron (LGVN) Prepaid Assets (2021 - 2026)
Longeveron's (LGVN) quarterly Prepaid Assets came in at $1.0 million in Q1 2026, up 11.97% year-on-year from $919000.0 in Q1 2025, and up 50.0% quarter-over-quarter from $686000.0 in Q4 2025.
Longeveron (LGVN) Prepaid Assets (2021 - 2026) Analysis & Trends
Longeveron's Prepaid Assets history runs 6 years deep, the most recent figure standing at $1.0 million for Q1 2026.
- On a quarterly basis, Prepaid Assets rose 11.97% year-over-year to $1.0 million in Q1 2026; TTM through Mar 2026 was $1.0 million, a 11.97% increase from a year earlier, with the FY2025 full-year figure at $686000.0, up 122.73% from the prior year.
- Prepaid Assets rose to $1.0 million in Q1 2026 per LGVN's latest filing, from $686000.0 in the prior quarter.
- Across five years, Prepaid Assets topped out at $1.5 million in Q2 2023 and bottomed at $308000.0 in Q4 2024.
- The 5-year median for Prepaid Assets is $911500.0 (2025), against an average of $859642.9.
- Across the five-year window, Prepaid Assets slumped 46.91% in 2024 and jumped 122.73% in 2025, its largest moves.
- Year by year, Prepaid Assets stood at $404000.0 in 2022, then declined by 6.93% to $376000.0 in 2023, then declined by 18.09% to $308000.0 in 2024, then soared by 122.73% to $686000.0 in 2025, then surged by 50.0% to $1.0 million in 2026.
- Per Business Quant, the three latest LGVN Prepaid Assets figures stand at $1.0 million (Q1 2026), $686000.0 (Q4 2025), and $1.0 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Longeveron | 3.97 Mn | -11.79 Mn | 264,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.03 Mn |
| Dec 31, 2025 | 686,000.00 |
| Sep 30, 2025 | 1.04 Mn |
| Jun 30, 2025 | 904,000.00 |
| Mar 31, 2025 | 919,000.00 |
| Dec 31, 2024 | 308,000.00 |
| Sep 30, 2024 | 609,000.00 |
| Jun 30, 2024 | 817,000.00 |
| Mar 31, 2024 | 1.29 Mn |
| Dec 31, 2023 | 376,000.00 |
| Sep 30, 2023 | 1.02 Mn |
| Jun 30, 2023 | 1.54 Mn |
| Mar 31, 2023 | 1.10 Mn |
| Dec 31, 2022 | 404,000.00 |
| Dec 31, 2021 | 282,000.00 |